Waters Corporation (NYSE:WAT) SVP Eugene G. Cassis sold 23,863 shares of the stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $197.53, for a total value of $4,713,658.39. Following the sale, the senior vice president now directly owns 15,100 shares in the company, valued at approximately $2,982,703. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of Waters Corporation (WAT) traded up $2.58 during mid-day trading on Friday, hitting $196.56. The company’s stock had a trading volume of 1,123,304 shares, compared to its average volume of 414,543. The firm has a market cap of $15,427.81, a P/E ratio of 26.94, a PEG ratio of 2.81 and a beta of 0.82. Waters Corporation has a 52-week low of $133.71 and a 52-week high of $201.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16.
Waters (NYSE:WAT) last issued its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.03. The firm had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.57 EPS. analysts expect that Waters Corporation will post 7.42 EPS for the current fiscal year.
A number of equities research analysts recently issued reports on WAT shares. Jefferies Group reissued a “hold” rating and set a $175.00 price target on shares of Waters in a research report on Thursday, August 31st. Goldman Sachs Group started coverage on Waters in a research report on Tuesday, September 26th. They set a “hold” rating and a $180.00 price target on the stock. Morgan Stanley reissued an “underweight” rating and set a $192.00 price target (up previously from $183.00) on shares of Waters in a research report on Friday, October 6th. Cleveland Research downgraded Waters from a “buy” rating to a “neutral” rating in a research report on Monday, October 9th. Finally, Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 price target on the stock in a research report on Monday, October 23rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Waters presently has a consensus rating of “Hold” and a consensus target price of $193.62.
Hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its holdings in shares of Waters by 0.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 209,081 shares of the medical instruments supplier’s stock valued at $38,436,000 after purchasing an additional 1,448 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Waters in the 3rd quarter valued at $3,446,000. Advisory Services Network LLC boosted its holdings in shares of Waters by 6.0% in the 2nd quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock valued at $210,000 after purchasing an additional 65 shares in the last quarter. UBS Asset Management Americas Inc. boosted its holdings in shares of Waters by 46.7% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 374,472 shares of the medical instruments supplier’s stock valued at $68,843,000 after purchasing an additional 119,130 shares in the last quarter. Finally, Chicago Equity Partners LLC acquired a new stake in shares of Waters in the 2nd quarter valued at $3,230,000. 92.29% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Waters Corporation (WAT) SVP Eugene G. Cassis Sells 23,863 Shares” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2017/12/16/waters-corporation-wat-svp-eugene-g-cassis-sells-23863-shares.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.